 |
News
• December 2009
Press Release
Inno Biologics and CEVEC Sign License Agreement for Human CAP® technology
• November 2009
Press Release
CEVEC raises €4M to finance strong growth of human CAP® technology
• October 2009
Press Release
InVivo and CEVEC Pharmaceuticals sign License Agreement
• March 2009
Press Release
CEVEC to launch CAP-T™Cell System
• February 2009
Press Release
Drug development program started based on
Human Cell Line
• October 2008
Press Release
New CEO at CEVEC Pharmaceuticals GmbH
• January 2008
Press Release
CEVEC again successful in challenge to Crucell patent
• October 2007
Visit us at the Biotechnica!
Hannover, Germany, 9. - 10. October 2007
You can find us in hall 9, stand F55
• August 2007
Press Release
CEVEC receives 0.5 Mio € from the BioChancePLUS program of the german BMBF
• June 2007
CEVEC's amniocyte production (CAP) technology was presented in detail in a talk given by Dr. Gudrun Schiedner, CSO, at the 20th Meeting of the European Society for Animal Cell Technology (ESACT) in Dresden, Germany, June 17-20, 2007.
• April 2007
Press Release
PharmaCell and CEVEC Pharmaceuticals sign Global Marketing & Sales Co-operation Agreement
• January 2007
Press Release
CEVEC Pharmaceuticals extends its management team and appoints Gero Waschütza, Ph.D. as new Chief Executive Officer
• December 2006
Press Release
CEVEC’s opposition against Crucell patent successful
• December 2006
CEVEC’s Amniocyte Production (CAP) technology was presented in detail in an oral presentation given by
Dr. Christoph Volpers, CEO, on the International Business Development Conference, Berlin, December 13-14, 2006, organized by BIO Deutschland and ebe, European Biopharmaceutical Enterprises.
• November 2006
CEVEC participated in successful Partnering Meetings at the BIO Europe 2006, Düsseldorf, Germany,
November 6-8, 2006. CEVEC was represented by
Dr. Christoph Volpers, CEO, and Dr. Gudrun Schiedner, CSO
• June 2006
Press Release
Legal patent dispute between CEVEC Pharmaceuticals GmbH and Crucell Holland B.V. settled
• May 2006
CEVEC is winner of the "Innovation Award" of the BIO 2006 Innovation Corridor Poster Session at Chicago, USA.
• April 2006
CEVEC Pharmaceuticals GmbH will be presenting at the BIO 2006, Chicago, USA, April 9-12, 2006
CEVEC will be participating in the BIO 2006 Business Forum’s Partnering Meetings being held at the McCormick Convention Center, April 10-12.
CEVEC will also participate in the Innovation Corridor Poster Presentation on Monday, April 10, 1:00 pm – 4:00 pm (Abstract No. B32).
The company will be represented by Dr. Christoph Volpers, CEO, and Dr. Klaus Binder, Business Development & Licensing.
• March 2006
CEVEC’s Amniocyte Production (CAP) system was presented in detail in an oral presentation given by Dr. Christoph Volpers, CEO, on the WilBio Europe Conference on Recombinant & Monoclonal Antibodies, Barcelona, Spain, March 6-8, 2006
• February 2006
CEVEC’s Amniocyte Production (CAP) system was presented on a poster by Dr. Gudrun Schiedner, CSO, on the BioProcess European Conference, Prague, Czech Republic, February 20-23, 2006
